Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Can biologic treatments influence the occurrence of infections in patients with rheumatoid arthritis?

Can biologic treatments influence the occurrence of infections in patients with rheumatoid arthritis?

Posted by on Jan 8, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the occurrence of infections and identified their risk factors in patients with rheumatoid arthritis (RA) that were treated with tofacitinib (Xeljanz) against those given a tumor necrosis factor inhibitor (TNFi). The data showed that serious and non-serious infections were higher in patients that received...

Read More

Can remission be increased in patients with rheumatoid arthritis by using more biologics and less corticosteroids under real-life conditions?

Can remission be increased in patients with rheumatoid arthritis by using more biologics and less corticosteroids under real-life conditions?

Posted by on Jan 3, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated the 7-year follow-up remission rate and maintenance in patients with rheumatoid arthritis (RA) under real-life conditions and identified factors related to long-term remission. The authors concluded that at 7 years nearly twice as many patients were in remission than at 1 year of follow-up and those patients had mainly...

Read More

How effective and safe is rituximab biosimilar HLX01 in patients with moderate to severe rheumatoid arthritis?

How effective and safe is rituximab biosimilar HLX01 in patients with moderate to severe rheumatoid arthritis?

Posted by on Dec 31, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated the effectiveness and safety of rituximab (Rituxan) biosimilar HLX01 combined with methotrexate (MTX; Trexall) in patients with moderate to severe rheumatoid arthritis (RA) following inadequate responses to MTX. The study showed that HLX01 added to MTX resulted in improvements compared to placebo in these...

Read More

Is the addition of low-dose prednisolone more beneficial than harmful to older patients with rheumatoid arthritis?

Is the addition of low-dose prednisolone more beneficial than harmful to older patients with rheumatoid arthritis?

Posted by on Oct 16, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the effectiveness and safety of daily administered prednisolone (Prelone) at a dose of 5 mg, as an add-on to the standard of care (SOC) in older patients with rheumatoid arthritis (RA). The authors concluded that low-dose prednisolone added to SOC had long-term benefits in these patients with a favorable balance of...

Read More

A review of the effect of vitamin E supplementation in patients with rheumatoid arthritis.

A review of the effect of vitamin E supplementation in patients with rheumatoid arthritis.

Posted by on Sep 18, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This review evaluated the safety and effectiveness of vitamin E supplementation in patients with rheumatoid arthritis (RA). The authors concluded that regular supplementation with vitamin E can help to improve the overall quality of life (QoL) in patients by reducing joint discomfort, swelling due to excessive fluid buildup in tissues...

Read More

Evaluating the effectiveness of different types of acupuncture therapies in the treatment of rheumatoid arthritis.

Evaluating the effectiveness of different types of acupuncture therapies in the treatment of rheumatoid arthritis.

Posted by on Sep 17, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This analysis compared the effectiveness of different acupuncture therapies combined with disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA). The data indicated that RA disease activity was most improved by combining electro-acupuncture and DMARDs while fire-needle or moxibustion plus DMARDs...

Read More

Can disease flare be predicted following remission and treatment withdrawal in patients with early rheumatoid arthritis?

Can disease flare be predicted following remission and treatment withdrawal in patients with early rheumatoid arthritis?

Posted by on Jun 1, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This study identified predictors of disease flare in patients with early, active rheumatoid arthritis (RA) that had stopped methotrexate (MTX; Otrexup) and/or abatacept (Orencia) treatment after clinical remission was achieved at 12 months. The data showed that patient function (HAQ-DI) and bone erosion based on magnetic resonance...

Read More

How effective is denosumab treatment in patients with rheumatoid arthritis?

How effective is denosumab treatment in patients with rheumatoid arthritis?

Posted by on Apr 29, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This review evaluated the effectiveness of denosumab (Prolia) on bone mineral density (BMD) and joint destruction in patients with rheumatoid arthritis (RA). The authors concluded that denosumab treatment was linked to increased BMD and reduced joint destruction in patients with RA. Some background RA is a chronic inflammatory...

Read More

Can filgotinib affect patient-reported outcomes and health-related quality of life in patients with rheumatoid arthritis?

Can filgotinib affect patient-reported outcomes and health-related quality of life in patients with rheumatoid arthritis?

Posted by on Apr 3, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the effect of filgotinib (Jyseleca) on patient-reported outcomes (PROs) and health-related quality of life (HRQoL) in patients that had active rheumatoid arthritis (RA). The study showed that filgotinib improved PROs in these patients and can be a treatment option for patients with insufficient responses to...

Read More

Comparing response to SARS-CoV-2 mRNA vaccine doses for patients with RA and healthy controls.

Comparing response to SARS-CoV-2 mRNA vaccine doses for patients with RA and healthy controls.

Posted by on Jan 19, 2022 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated immune responses after two doses of SARS-CoV-2 messenger RNA (mRNA) vaccines in patients with inflammatory joint diseases including rheumatoid arthritis (RA) compared to healthy controls (HCs). The data showed that patients with inflammatory joint diseases had similar responses to mRNA vaccines after 2...

Read More

Impact of 5-year baricitinib treatment for active, rheumatoid arthritis in preventing radiographic progression of joint damage.

Impact of 5-year baricitinib treatment for active, rheumatoid arthritis in preventing radiographic progression of joint damage.

Posted by on Oct 25, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated the effect of oral baricitinib (Olumiant) on the prevention of radiographic progression of joint damage over 5 years in patients with active rheumatoid arthritis (RA). The data showed that patients treated with oral baricitinib had less radiographic progression over 5 years, compared to those initially given a...

Read More

Treatment responses to tofacitinib with additional therapies in patients with rheumatoid arthritis.

Treatment responses to tofacitinib with additional therapies in patients with rheumatoid arthritis.

Posted by on Oct 16, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the responses of patients with rheumatoid arthritis (RA) to tofacitinib (Xeljanz), tofacitinib with methotrexate (MTX; Otrexup), and adalimumab (Humira) with MTX. The data showed that some patients did not require combined therapy to achieve higher responses, however, overall, greater responses were achieved with...

Read More